60¢sixtycents

Revolution Medicines, Inc.RVMD

Is RVMD cheap right now? Every multiple below is scored against its own 10-year range, not a sector average.

$190.27+1.55 (+0.82%)24:00 UTC
NASDAQHealthcare

Company snapshot

Market Cap
$40B
Large-cap
+4019%
2020 — today
10-Year Price
+612%
2020 — today
52-Week Range
$58.57$221.15
Current $190.27· 81%

Revolution Medicines is a clinical-stage precision oncology firm focused on novel pathways driving RAS-addicted cancers. Based in Redwood City, California, the company develops a pipeline of targeted inhibitors, including SHP2 inhibitor RMC-4630 (partnered with Sanofi), SOS1 inhibitor RMC-5845, and mTORC1 inhibitor RMC-5552. Its research prioritizes active RAS(ON) variants, advancing candidates like RMC-6291 and RMC-6236, alongside programs targeting KRASG13C(ON) and KRASG12D(ON) mutations.

Similar companies

Healthcare companies of comparable size to RVMD
CompanyP/EDiv yield
ONCBeOne Medicines Ltd.5.1—
ALCAlcon Inc.54.70.5%
IDXXIDEXX Laboratories, Inc.40.8—
CNCCentene Corporation23.5—
ZTSZoetis Inc.13.02.7%
TEVATeva Pharmaceutical Industries Limited69.1—
HUMHumana Inc.39.50.6%
AAgilent Technologies, Inc.35.70.4%

Healthcare companies of comparable size — each one shown against its own 10-year range, not a sector average. Browse all stocks we cover.

Valuation in context

P/E ratio
-21.5
N/A
Not meaningful — company is unprofitable
Sector median 25.2below sector
P/B ratio
15.4
Near historic high
Near historic highs — last 10 years
Sector median 2.2above sector
FCF Yield
-3.1%
Near historic high
Near historic highs — last 10 years
Sector median -12.6%above sector
Free · No credit card needed

Get alerted when RVMD is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.